In contrast, in H1299 tumours, 20 days after treatment, we detected a decrease of phosphorylation of MEK and ERK kinases in tumours expressing the pan-RAS degrader (Supplementary Fig. 9f) and not the KRAS degrader (Supplementary Fig. 9g). The gene discussed is MAP2K7; the disease is neoplasm.